Literature DB >> 20668859

Cholecystokinin octapeptide (CCK-8): friend or foe for rheumatoid arthritis?

Rui-Xue Leng, Hai-Feng Pan, Jin-Hui Tao, Dong-Qing Ye.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668859     DOI: 10.1007/s00296-010-1582-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  5 in total

1.  Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.

Authors:  Laurie E Harrington; Robin D Hatton; Paul R Mangan; Henrietta Turner; Theresa L Murphy; Kenneth M Murphy; Casey T Weaver
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

Review 2.  Th1 and Th17 cells: adversaries and collaborators.

Authors:  Jesse M Damsker; Anna M Hansen; Rachel R Caspi
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

3.  IL-12 can alleviate Th17-mediated allergic lung inflammation through induction of pulmonary IL-10 expression.

Authors:  D M Durrant; D W Metzger
Journal:  Mucosal Immunol       Date:  2010-03-17       Impact factor: 7.313

4.  Cholecystokinin octapeptide exerts its therapeutic effects on collagen-induced arthritis by suppressing both inflammatory and Th17 responses.

Authors:  Qiaoxia Li; Bin Cong; Baoen Shan; Jingge Zhang; Haiying Chen; Tao Wang; Chunling Ma; Jin Qin; Di Wen; Feng Yu
Journal:  Rheumatol Int       Date:  2010-04-08       Impact factor: 2.631

5.  Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis.

Authors:  Shehzad Z Sheikh; Katsuyoshi Matsuoka; Taku Kobayashi; Fengling Li; Tara Rubinas; Scott E Plevy
Journal:  J Immunol       Date:  2010-03-12       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.